(Q37145373)

18 August 2017

1 reference

title

Medication-induced osteoporosis (English)

1 reference

18 August 2017

0 references

Meng-Yi Weng

1

1 reference

PubMed ID

18430387

18 August 2017

Nancy E Lane

series ordinal

2

1 reference

18 August 2017

1 December 2007

1 reference

Current osteoporosis reports

18 August 2017

1 reference

18 August 2017

5

1 reference

18 August 2017

4

1 reference

18 August 2017

139-145

1 reference

https://scigraph.springernature.com/pub.10.1007/s11914-007-0008-y

18 August 2017

0 references

cites work

Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. A randomized, double-blind, placebo-controlled trial

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11914-007-0008-Y

Effect of antiepileptic drugs on bone density in ambulatory patients

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11914-007-0008-Y

Antiepileptic drug use increases rates of bone loss in older women: a prospective study

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11914-007-0008-Y

The science and therapy of glucocorticoid-induced bone loss.

21 January 2018

1 reference

12 December 2020

Bone mineral density in asthmatic women on high-dose inhaled beclomethasone dipropionate

1 reference

12 December 2020

Randomized controlled trial of annual zoledronic acid to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer.

1 reference

12 December 2020

Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group

1 reference

12 December 2020

The diagnosis and treatment of osteoporosis in men on androgen deprivation therapy for advanced carcinoma of the prostate

1 reference

12 December 2020

Zoledronic Acid Prevents Cancer Treatment–Induced Bone Loss in Premenopausal Women Receiving Adjuvant Endocrine Therapy for Hormone-Responsive Breast Cancer: A Report From the Austrian Breast and Colorectal Cancer Study Group

1 reference

12 December 2020

Inhaled corticosteroids: benefits and risks

1 reference

12 December 2020

Corticosteroids and fractures: a close encounter of the third cell kind.

1 reference

12 December 2020

Risedronate therapy prevents corticosteroid-induced bone loss: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study

1 reference

12 December 2020

Risk of clinical fractures after gonadotropin-releasing hormone agonist therapy for prostate cancer

1 reference

12 December 2020

Fracture risk among breast cancer survivors: results from the Women's Health Initiative Observational Study.

1 reference

12 December 2020

Glucocorticoid-treated mice have localized changes in trabecular bone material properties and osteocyte lacunar size that are not observed in placebo-treated or estrogen-deficient mice

1 reference

12 December 2020

Glucocorticoids suppress bone formation via the osteoclast

1 reference

12 December 2020

Prevention of corticosteroid-induced osteoporosis with salmon calcitonin in sarcoid patients

1 reference

12 December 2020

Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. European Corticosteroid-Induced Osteoporosis Treatment Study

1 reference

12 December 2020

Changes on bone mineral density after adjuvant treatment in women with non-metastatic breast cancer

1 reference

12 December 2020

Daily treatment with parathyroid hormone is associated with an increase in vertebral cross-sectional area in postmenopausal women with glucocorticoid-induced osteoporosis.

1 reference

12 December 2020

Targeting the Wnt/beta-catenin pathway to regulate bone formation in the adult skeleton

1 reference

12 December 2020

Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer

1 reference

12 December 2020

Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. A randomized, controlled study

1 reference

12 December 2020

Quantifying osteoblast and osteocyte apoptosis: challenges and rewards

1 reference

12 December 2020

Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial

1 reference

12 December 2020

The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis

1 reference

12 December 2020

Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry

1 reference

12 December 2020

Estrogen-dependent increase in bone turnover and bone loss in postmenopausal women with breast cancer treated with anastrozole. Prevention with bisphosphonates

1 reference

12 December 2020

The pathogenesis, epidemiology and management of glucocorticoid-induced osteoporosis

1 reference

12 December 2020

Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial

1 reference

12 December 2020

A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer

1 reference

12 December 2020

Incidence of Anticonvulsant Osteomalacia and Effect of Vitamin D: Controlled Therapeutic Trial

1 reference

12 December 2020

Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis

1 reference

12 December 2020

Risk of fracture after androgen deprivation for prostate cancer

1 reference

12 December 2020

Prevention of further bone mass loss by nasal calcitonin in patients on long term glucocorticoid therapy for asthma: a two year follow up study

1 reference

12 December 2020

Inhaled corticosteroid use and bone-mineral density in patients with asthma

1 reference

12 December 2020

Fracture risk associated with use of antiepileptic drugs

1 reference

12 December 2020

Histomorphometric analysis of glucocorticoid-induced osteoporosis

1 reference

12 December 2020

Decreased bone mineral density in premenopausal asthma patients receiving long-term inhaled steroids

1 reference

12 December 2020

Use of inhaled corticosteroids and risk of fractures.

1 reference

12 December 2020

Increasing use of gonadotropin-releasing hormone agonists for the treatment of localized prostate carcinoma

1 reference

12 December 2020

Zoledronic acid inhibits adjuvant letrozole-induced bone loss in postmenopausal women with early breast cancer

1 reference

12 December 2020

Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: a 3 year followup

1 reference

12 December 2020

American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer

1 reference

12 December 2020

Testosterone therapy in glucocorticoid-treated men

1 reference

12 December 2020

Effects of inhaled glucocorticoids on bone density in premenopausal women

1 reference

12 December 2020

Effect of glucocorticoid replacement therapy on bone mineral density in patients with Addison disease

1 reference

12 December 2020

Prevention of bone loss in survivors of breast cancer: A randomized, double-blind, placebo-controlled clinical trial

1 reference

12 December 2020

Long-term proton pump inhibitor therapy and risk of hip fracture

1 reference

12 December 2020

Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis

1 reference

12 December 2020

10.1007/S11914-007-0008-Y

Identifiers

DOI

1 reference

18 August 2017

1 reference

PubMed ID

18430387